Medication info
Dibis XR Tablet 500 Milligrams

Dibis XR Tablet 500 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
White, bilaterally convex, rectangular extended-release tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202000084 · Approved 2020.01.06 · Insurance code 648508000

Summary

Main use
Treatment of type 2 diabetes mellitus in adults
Who takes it
Adults
Adult dose
The dosage should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is one 500mg metformin hydrochloride extended-release tablet once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose escalation. The maximum dose is 2000mg per day. - When increasing the dose, increase it by 500mg each week; up to a maximum of 2000mg per day may be taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already being treated with metformin tablets, the initial dose of this product is the same as the daily dose of immediate-release metformin tablets. Switching to this product is not recommended for patients taking 2000mg or more of immediate-release metformin per day. - At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess response to this medicine and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, respectively, this medicine should be discontinued immediately.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus in adults

  • Type 2 diabetes with insufficient blood sugar control
  • diabetes in overweight individuals
View approved original text

This drug is used for the treatment of adult patients with type 2 diabetes who find it difficult to control blood sugar levels with diet and exercise alone, particularly for those who are overweight. It may be used alone or, if necessary, in combination with other oral hypoglycemics or insulin to help effectively control blood sugar levels. This contributes to stabilizing blood sugar levels and aids in diabetes management.

How to take

Adult dose

The dosage should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is one 500mg metformin hydrochloride extended-release tablet once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose escalation. The maximum dose is 2000mg per day. - When increasing the dose, increase it by 500mg each week; up to a maximum of 2000mg per day may be taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already being treated with metformin tablets, the initial dose of this product is the same as the daily dose of immediate-release metformin tablets. Switching to this product is not recommended for patients taking 2000mg or more of immediate-release metformin per day. - At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess response to this medicine and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73m2, respectively, this medicine should be discontinued immediately.

Precautions

This drug can rarely cause a serious side effect known as lactic acidosis, so if symptoms occur, notify medical personnel immediately. When used in conjunction with other diabetes medications, there is a risk of hypoglycemia, so caution is warranted. Patients with moderate or severe renal impairment or acute illness should not use this drug. Administration should be temporarily halted before and after surgeries, during severe infections, or in cases of dehydration, and should be resumed only after renal function has recovered. Women who are pregnant or breastfeeding should make careful judgments regarding the use of this drug and consult with their doctor if necessary. During the course of treatment with this drug, regular checks of renal function and blood sugar levels should be performed to detect any abnormalities. Alcohol consumption may increase the risk of side effects from this drug, so it is advisable to avoid drinking during treatment. This drug may cause side effects such as gastrointestinal disturbances, altered taste, and vitamin B12 deficiency; thus, patients should inform their doctor if symptoms persist. This drug may interact with other medications, so it is essential to inform the medical personnel of any other medications being taken. Elderly patients may have reduced renal function, necessitating dosage adjustments and regular monitoring. This drug should be swallowed whole without chewing or crushing, and passing the tablet shell in the stool is normal.

Side effects

  • severe lactic acidosis
  • severe hypoglycemia
  • vitamin B12 deficiency
  • taste impairment
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • erythema
Show 3 more
  • pruritus
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White, bilaterally convex, rectangular extended-release tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.